Americans rely on the U.S. Food and Drug Administration to ensure that food labels contain updated nutritional information to help them make more informed food choices that lead to better health for themselves and their families. I’ve made nutrition one of my top priorities, and ensuring that consumers have accurate and science-based information concerning the link between diet and chronic diseases like diabetes, obesity and heart disease is part of that commitment. We need to advance new ways to use the science we’re learning about diet and nutrition as tools for reducing the burden of disease. Our update to the iconic Nutrition Facts label includes significant changes to help consumers make more informed dietary choices, and we are already seeing the new label on many products.
Category Archives: Food Safety News
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines
FDA provides update on flu vaccines during this severe flu season
Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A
FDA provides update on Clarity-BPA
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine
FDA provides update on flu vaccines during this severe flu season
FDA expands treatment window for use of clot retrieval devices in certain stroke patients
FDA expands treatment window for use of clot retrieval devices in certain stroke patient
Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs
FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease
FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint
FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients